Product image of Hemosol B0 (Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate) supplied by GNH India

Hemosol B0

Active Ingredient:
Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate
Origin:
EU

Hemosol B0 (Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate)

Hemosol B0 is a sterile electrolyte solution for injection that contains calcium, lactic acid, magnesium, sodium, chloride ion, and hydrogen carbonate. It is supplied as a ready‑to‑use liquid for intravenous administration during hemodialysis. The formulation provides essential electrolytes and buffering capacity to support acid‑base balance in patients undergoing renal replacement therapy. It is marketed in the European Union and conforms to EU pharmacopeial standards for purity and sterility.

Manufacturer / TM Owner

Vantive Belgium

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hemosol B0 is indicated for use as the dialysate solution in hemodialysis and other renal replacement therapies. It supplies the electrolytes and buffering agents required to maintain physiological homeostasis during treatment.

  • Provides calcium, magnesium, sodium, chloride, and bicarbonate during dialysis.
  • Helps regulate acid‑base balance through lactic acid buffering.
  • Supports cardiovascular stability by maintaining electrolyte concentrations.
  • Compatible with standard hemodialysis machines and circuits.
  • Used in continuous renal replacement therapy (CRRT) where precise electrolyte control is needed.

Side Effects

Adverse reactions to Hemosol B0 are generally related to its electrolyte composition and are reported infrequently.

Common

  • Mild nausea or vomiting.
  • Transient hypotension during dialysis.
  • Mild pruritus at the infusion site.

Serious

  • Severe hypercalcemia or hypermagnesemia.
  • Metabolic alkalosis.
  • Cardiac arrhythmias related to electrolyte imbalance.
  • Anaphylactic reactions to solution components.

Precautions & Warnings

When using Hemosol B0, clinicians should assess patient-specific factors and monitor laboratory values to minimize risks.

  • Verify baseline serum calcium, magnesium, and bicarbonate levels before initiation.
  • Adjust dialysate composition for patients with known electrolyte disorders.
  • Use caution in patients with cardiac disease or arrhythmias.
  • Monitor blood pressure and heart rate throughout the session.
  • Observe for signs of fluid overload or electrolyte shifts.
  • Avoid use in patients with known hypersensitivity to any component.
  • Ensure proper storage at recommended temperature to maintain solution stability.

Avoid Interactions

Hemosol B0 may interact with medications that affect electrolyte balance or acid‑base status.

Avoid

  • Calcium channel blockers that could exacerbate hypercalcemia.
  • Magnesium‑containing laxatives or antacids when high magnesium levels are present.
  • Sodium bicarbonate infusions that may cause excessive alkalinity.

Use with caution

  • Loop diuretics that alter sodium and calcium excretion.
  • ACE inhibitors or ARBs in patients prone to hyperkalemia.
  • Vitamin D analogues that increase calcium absorption.
  • Blood transfusions that may affect serum calcium concentrations.

Frequently Asked Questions

Hemosol B0 includes calcium, magnesium, sodium, chloride ion, and hydrogen carbonate, with lactic acid serving as a buffering agent.

The solution is connected to the dialysis machine and delivered intravenously as the dialysate that circulates across the semipermeable membrane.

Yes, Hemosol B0 is suitable for CRRT where precise control of electrolyte concentrations is required.

Clinicians should monitor serum calcium, magnesium, bicarbonate, blood pressure, heart rate, and overall fluid balance throughout the dialysis session.

Hemosol B0 is formulated to be compatible with standard hemodialysis equipment, but manufacturers’ guidelines should be consulted for specific models.

The dialysate composition may need adjustment, and the patient should be evaluated for underlying causes; clinical decisions should follow established protocols.

Hemosol B0 should be avoided in patients with known hypersensitivity to any of its components.

Lactic acid acts as a buffering agent, helping to maintain acid‑base balance during dialysis.

The solution should be stored at the temperature recommended by the manufacturer, typically between 2 °C and 8 °C, and protected from light.

Use in pediatric patients should follow specific clinical guidelines and dosing adjustments based on age and weight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.